Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXD1
|
ENSG00000251493.2 | forkhead box D1 |
FOXO1
|
ENSG00000150907.6 | forkhead box O1 |
FOXO6
|
ENSG00000204060.4 | forkhead box O6 |
FOXG1
|
ENSG00000176165.7 | forkhead box G1 |
FOXP1
|
ENSG00000114861.14 | forkhead box P1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXP1 | hg19_v2_chr3_-_71632894_71632909 | -0.17 | 3.6e-01 | Click! |
FOXO6 | hg19_v2_chr1_+_41827594_41827594 | -0.10 | 6.1e-01 | Click! |
FOXO1 | hg19_v2_chr13_-_41240717_41240735 | -0.10 | 6.2e-01 | Click! |
FOXG1 | hg19_v2_chr14_+_29234870_29235050, hg19_v2_chr14_+_29236269_29236287 | 0.08 | 6.7e-01 | Click! |
FOXD1 | hg19_v2_chr5_-_72744336_72744359 | 0.05 | 8.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_116654376 | 9.57 |
ENST00000369500.3
|
MAB21L3
|
mab-21-like 3 (C. elegans) |
chr2_-_165424973 | 5.31 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr11_+_117049910 | 3.56 |
ENST00000431081.2
ENST00000524842.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr1_+_152486950 | 3.52 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
chr1_-_201096312 | 2.94 |
ENST00000449188.2
|
ASCL5
|
achaete-scute family bHLH transcription factor 5 |
chr6_+_101847105 | 2.74 |
ENST00000369137.3
ENST00000318991.6 |
GRIK2
|
glutamate receptor, ionotropic, kainate 2 |
chr10_-_101841588 | 2.41 |
ENST00000370418.3
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
chr18_+_3449330 | 2.28 |
ENST00000549253.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr12_+_96588279 | 2.23 |
ENST00000552142.1
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr1_-_27816556 | 2.06 |
ENST00000536657.1
|
WASF2
|
WAS protein family, member 2 |
chr17_-_8059638 | 2.02 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
chr15_-_60884706 | 2.02 |
ENST00000449337.2
|
RORA
|
RAR-related orphan receptor A |
chr12_+_13349650 | 1.98 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr19_-_45909585 | 1.83 |
ENST00000593226.1
ENST00000418234.2 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr11_-_34535297 | 1.78 |
ENST00000532417.1
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chrX_-_106960285 | 1.73 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr15_-_70994612 | 1.67 |
ENST00000558758.1
ENST00000379983.2 ENST00000560441.1 |
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr11_+_117049445 | 1.64 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr1_+_24645865 | 1.61 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr9_-_84303269 | 1.59 |
ENST00000418319.1
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
chr1_+_24645807 | 1.58 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr1_+_24646002 | 1.57 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr5_+_78532003 | 1.56 |
ENST00000396137.4
|
JMY
|
junction mediating and regulatory protein, p53 cofactor |
chr1_-_45956800 | 1.52 |
ENST00000538496.1
|
TESK2
|
testis-specific kinase 2 |
chr8_+_70404996 | 1.46 |
ENST00000402687.4
ENST00000419716.3 |
SULF1
|
sulfatase 1 |
chr11_+_117049854 | 1.45 |
ENST00000278951.7
|
SIDT2
|
SID1 transmembrane family, member 2 |
chr9_-_98269699 | 1.41 |
ENST00000429896.2
|
PTCH1
|
patched 1 |
chrX_+_135251835 | 1.40 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chrX_+_135251783 | 1.37 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr4_-_152149033 | 1.33 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
chr6_+_74405501 | 1.31 |
ENST00000437994.2
ENST00000422508.2 |
CD109
|
CD109 molecule |
chr7_+_106809406 | 1.31 |
ENST00000468410.1
ENST00000478930.1 ENST00000464009.1 ENST00000222574.4 |
HBP1
|
HMG-box transcription factor 1 |
chr3_+_188889737 | 1.31 |
ENST00000345063.3
|
TPRG1
|
tumor protein p63 regulated 1 |
chr10_+_111985713 | 1.31 |
ENST00000239007.7
|
MXI1
|
MAX interactor 1, dimerization protein |
chr14_+_24583836 | 1.29 |
ENST00000559115.1
ENST00000558215.1 ENST00000557810.1 ENST00000561375.1 ENST00000446197.3 ENST00000559796.1 ENST00000560713.1 ENST00000560901.1 ENST00000559382.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr6_+_74405804 | 1.29 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
chr11_+_10476851 | 1.29 |
ENST00000396553.2
|
AMPD3
|
adenosine monophosphate deaminase 3 |
chr12_-_52779433 | 1.27 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr11_-_111781454 | 1.27 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr11_-_111781610 | 1.26 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr1_+_203651937 | 1.24 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr2_-_190044480 | 1.24 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr11_+_33061543 | 1.23 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
chr10_+_99400443 | 1.18 |
ENST00000370631.3
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha |
chr11_-_111781554 | 1.16 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr15_-_34629922 | 1.14 |
ENST00000559484.1
ENST00000354181.3 ENST00000558589.1 ENST00000458406.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr18_+_28898052 | 1.14 |
ENST00000257192.4
|
DSG1
|
desmoglein 1 |
chr12_-_92539614 | 1.14 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chrX_+_37865804 | 1.13 |
ENST00000297875.2
ENST00000357972.5 |
SYTL5
|
synaptotagmin-like 5 |
chr19_+_12902289 | 1.12 |
ENST00000302754.4
|
JUNB
|
jun B proto-oncogene |
chr15_-_34630234 | 1.12 |
ENST00000558667.1
ENST00000561120.1 ENST00000559236.1 ENST00000397702.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr4_+_15376165 | 1.10 |
ENST00000382383.3
ENST00000429690.1 |
C1QTNF7
|
C1q and tumor necrosis factor related protein 7 |
chr6_+_32121908 | 1.10 |
ENST00000375143.2
ENST00000424499.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr5_+_72251857 | 1.10 |
ENST00000507345.2
ENST00000512348.1 ENST00000287761.6 |
FCHO2
|
FCH domain only 2 |
chr7_-_140624499 | 1.09 |
ENST00000288602.6
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B |
chr6_-_159466042 | 1.09 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr2_-_134326009 | 1.08 |
ENST00000409261.1
ENST00000409213.1 |
NCKAP5
|
NCK-associated protein 5 |
chr16_+_86612112 | 1.07 |
ENST00000320241.3
|
FOXL1
|
forkhead box L1 |
chr11_+_34654011 | 1.06 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr6_+_32121789 | 1.05 |
ENST00000437001.2
ENST00000375137.2 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr14_+_24584508 | 1.02 |
ENST00000559354.1
ENST00000560459.1 ENST00000559593.1 ENST00000396941.4 ENST00000396936.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr14_-_36988882 | 1.02 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr20_+_2082494 | 1.00 |
ENST00000246032.3
|
STK35
|
serine/threonine kinase 35 |
chr1_-_27816641 | 0.99 |
ENST00000430629.2
|
WASF2
|
WAS protein family, member 2 |
chr5_+_72251793 | 0.98 |
ENST00000430046.2
ENST00000341845.6 |
FCHO2
|
FCH domain only 2 |
chr2_+_70142232 | 0.98 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
chr8_+_26150628 | 0.98 |
ENST00000523925.1
ENST00000315985.7 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr5_-_150460539 | 0.97 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr22_-_31688431 | 0.96 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr1_-_151778630 | 0.92 |
ENST00000368820.3
|
LINGO4
|
leucine rich repeat and Ig domain containing 4 |
chr12_+_96588143 | 0.92 |
ENST00000228741.3
ENST00000547249.1 |
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr10_-_103578182 | 0.91 |
ENST00000439817.1
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase) |
chr10_-_21435488 | 0.90 |
ENST00000534331.1
ENST00000529198.1 ENST00000377118.4 |
C10orf113
|
chromosome 10 open reading frame 113 |
chr8_+_126442563 | 0.90 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr14_-_74551096 | 0.89 |
ENST00000350259.4
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
chr12_+_121416340 | 0.89 |
ENST00000257555.6
ENST00000400024.2 |
HNF1A
|
HNF1 homeobox A |
chr16_+_4421841 | 0.88 |
ENST00000304735.3
|
VASN
|
vasorin |
chr7_+_129906660 | 0.88 |
ENST00000222481.4
|
CPA2
|
carboxypeptidase A2 (pancreatic) |
chr1_+_84630367 | 0.87 |
ENST00000370680.1
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr1_+_209878182 | 0.87 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr14_-_24584138 | 0.86 |
ENST00000558280.1
ENST00000561028.1 |
NRL
|
neural retina leucine zipper |
chr5_-_150460914 | 0.84 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr8_-_40755333 | 0.84 |
ENST00000297737.6
ENST00000315769.7 |
ZMAT4
|
zinc finger, matrin-type 4 |
chr12_+_121416489 | 0.84 |
ENST00000541395.1
ENST00000544413.1 |
HNF1A
|
HNF1 homeobox A |
chr6_+_139094657 | 0.83 |
ENST00000332797.6
|
CCDC28A
|
coiled-coil domain containing 28A |
chr2_+_132479948 | 0.82 |
ENST00000355171.4
|
C2orf27A
|
chromosome 2 open reading frame 27A |
chr11_-_85780853 | 0.82 |
ENST00000531930.1
ENST00000528398.1 |
PICALM
|
phosphatidylinositol binding clathrin assembly protein |
chr19_+_50380917 | 0.81 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr4_+_187148556 | 0.79 |
ENST00000264690.6
ENST00000446598.2 ENST00000414291.1 ENST00000513864.1 |
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1 |
chr1_-_45956822 | 0.78 |
ENST00000372086.3
ENST00000341771.6 |
TESK2
|
testis-specific kinase 2 |
chr15_-_34610962 | 0.78 |
ENST00000290209.5
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr5_-_38557561 | 0.78 |
ENST00000511561.1
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chrX_+_135252050 | 0.77 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
chr4_-_21950356 | 0.76 |
ENST00000447367.2
ENST00000382152.2 |
KCNIP4
|
Kv channel interacting protein 4 |
chr12_-_71031185 | 0.76 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr10_-_45474237 | 0.75 |
ENST00000448778.1
ENST00000298295.3 |
C10orf10
|
chromosome 10 open reading frame 10 |
chrX_-_15619076 | 0.75 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
chr17_-_64225508 | 0.74 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr12_-_56352368 | 0.74 |
ENST00000549404.1
|
PMEL
|
premelanosome protein |
chr3_-_48956818 | 0.74 |
ENST00000408959.2
|
ARIH2OS
|
ariadne homolog 2 opposite strand |
chr1_-_115259337 | 0.72 |
ENST00000369535.4
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog |
chr12_-_772901 | 0.72 |
ENST00000305108.4
|
NINJ2
|
ninjurin 2 |
chr17_+_58755184 | 0.71 |
ENST00000589222.1
ENST00000407086.3 ENST00000390652.5 |
BCAS3
|
breast carcinoma amplified sequence 3 |
chr14_-_74551172 | 0.71 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
chr22_-_31688381 | 0.71 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr16_-_30107491 | 0.71 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chr15_-_70387120 | 0.71 |
ENST00000539550.1
|
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
chr9_+_75229616 | 0.71 |
ENST00000340019.3
|
TMC1
|
transmembrane channel-like 1 |
chr19_+_50380682 | 0.71 |
ENST00000221543.5
|
TBC1D17
|
TBC1 domain family, member 17 |
chr6_-_27880174 | 0.70 |
ENST00000303324.2
|
OR2B2
|
olfactory receptor, family 2, subfamily B, member 2 |
chr4_-_164534657 | 0.70 |
ENST00000339875.5
|
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr5_-_146435694 | 0.70 |
ENST00000356826.3
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr1_+_84630645 | 0.70 |
ENST00000394839.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr8_-_124553437 | 0.68 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr5_-_146435501 | 0.67 |
ENST00000336640.6
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr20_+_306177 | 0.67 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr9_-_136933615 | 0.67 |
ENST00000371834.2
|
BRD3
|
bromodomain containing 3 |
chr12_-_71031220 | 0.66 |
ENST00000334414.6
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr20_+_52105495 | 0.66 |
ENST00000439873.2
|
AL354993.1
|
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
chr11_-_34535332 | 0.66 |
ENST00000257832.2
ENST00000429939.2 |
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chr5_-_146435572 | 0.66 |
ENST00000394414.1
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr1_+_145438469 | 0.65 |
ENST00000369317.4
|
TXNIP
|
thioredoxin interacting protein |
chr8_-_8318847 | 0.65 |
ENST00000521218.1
|
CTA-398F10.2
|
CTA-398F10.2 |
chr9_+_134165063 | 0.65 |
ENST00000372264.3
|
PPAPDC3
|
phosphatidic acid phosphatase type 2 domain containing 3 |
chr20_-_43150601 | 0.63 |
ENST00000541235.1
ENST00000255175.1 ENST00000342374.4 |
SERINC3
|
serine incorporator 3 |
chr2_+_175260451 | 0.63 |
ENST00000458563.1
ENST00000409673.3 ENST00000272732.6 ENST00000435964.1 |
SCRN3
|
secernin 3 |
chr9_+_135457530 | 0.63 |
ENST00000263610.2
|
BARHL1
|
BarH-like homeobox 1 |
chr4_-_111119804 | 0.63 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr10_-_103578162 | 0.62 |
ENST00000361464.3
ENST00000357797.5 ENST00000370094.3 |
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase) |
chr2_-_71454185 | 0.61 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr3_+_178866199 | 0.60 |
ENST00000263967.3
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
chr4_-_116034979 | 0.60 |
ENST00000264363.2
|
NDST4
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
chrX_+_70316005 | 0.59 |
ENST00000374259.3
|
FOXO4
|
forkhead box O4 |
chr18_+_56530136 | 0.59 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
chr7_-_121944491 | 0.59 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr2_+_158114051 | 0.59 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr8_-_71316021 | 0.59 |
ENST00000452400.2
|
NCOA2
|
nuclear receptor coactivator 2 |
chr1_-_28503693 | 0.58 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr7_-_81399411 | 0.58 |
ENST00000423064.2
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr11_+_63606373 | 0.58 |
ENST00000402010.2
ENST00000315032.8 ENST00000377809.4 ENST00000413835.2 ENST00000377810.3 |
MARK2
|
MAP/microtubule affinity-regulating kinase 2 |
chr4_-_123377880 | 0.58 |
ENST00000226730.4
|
IL2
|
interleukin 2 |
chr9_+_126131131 | 0.57 |
ENST00000373629.2
|
CRB2
|
crumbs homolog 2 (Drosophila) |
chr1_-_168106536 | 0.57 |
ENST00000537209.1
ENST00000361697.2 ENST00000546300.1 ENST00000367835.1 |
GPR161
|
G protein-coupled receptor 161 |
chr2_-_214016314 | 0.57 |
ENST00000434687.1
ENST00000374319.4 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr7_-_81399355 | 0.56 |
ENST00000457544.2
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr11_+_63606477 | 0.55 |
ENST00000508192.1
ENST00000361128.5 |
MARK2
|
MAP/microtubule affinity-regulating kinase 2 |
chr12_+_131438443 | 0.55 |
ENST00000261654.5
|
GPR133
|
G protein-coupled receptor 133 |
chr8_-_134309823 | 0.55 |
ENST00000414097.2
|
NDRG1
|
N-myc downstream regulated 1 |
chr17_-_36358166 | 0.54 |
ENST00000537432.1
|
TBC1D3
|
TBC1 domain family, member 3 |
chr12_+_6881678 | 0.53 |
ENST00000441671.2
ENST00000203629.2 |
LAG3
|
lymphocyte-activation gene 3 |
chr1_+_20512568 | 0.53 |
ENST00000375099.3
|
UBXN10
|
UBX domain protein 10 |
chr10_+_30722866 | 0.52 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chrX_-_19688475 | 0.52 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr2_+_74120094 | 0.51 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
chr1_+_174933899 | 0.51 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr12_+_50135327 | 0.51 |
ENST00000549966.1
ENST00000547832.1 ENST00000547187.1 ENST00000548894.1 ENST00000546914.1 ENST00000552699.1 ENST00000267115.5 |
TMBIM6
|
transmembrane BAX inhibitor motif containing 6 |
chr8_+_22132847 | 0.51 |
ENST00000521356.1
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2 |
chr8_-_134309335 | 0.51 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
chr19_-_38743878 | 0.51 |
ENST00000587515.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr6_-_159466136 | 0.51 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr2_-_160472952 | 0.51 |
ENST00000541068.2
ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr7_+_143701022 | 0.50 |
ENST00000408922.2
|
OR6B1
|
olfactory receptor, family 6, subfamily B, member 1 |
chr16_-_30122717 | 0.50 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr5_-_131132614 | 0.50 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr8_-_28243934 | 0.50 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
chr1_-_26394114 | 0.50 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
chr17_-_46035187 | 0.50 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
chr5_-_142783175 | 0.50 |
ENST00000231509.3
ENST00000394464.2 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr10_+_95848824 | 0.50 |
ENST00000371385.3
ENST00000371375.1 |
PLCE1
|
phospholipase C, epsilon 1 |
chr8_+_128748466 | 0.50 |
ENST00000524013.1
ENST00000520751.1 |
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr9_+_78505554 | 0.50 |
ENST00000545128.1
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5 |
chr10_-_90751038 | 0.50 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr2_+_70142189 | 0.50 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr8_+_52730143 | 0.49 |
ENST00000415643.1
|
AC090186.1
|
Uncharacterized protein |
chr5_-_159846399 | 0.49 |
ENST00000297151.4
|
SLU7
|
SLU7 splicing factor homolog (S. cerevisiae) |
chr20_-_50179368 | 0.49 |
ENST00000609943.1
ENST00000609507.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
chr21_-_19775973 | 0.49 |
ENST00000284885.3
|
TMPRSS15
|
transmembrane protease, serine 15 |
chr11_+_63606558 | 0.49 |
ENST00000350490.7
ENST00000502399.3 |
MARK2
|
MAP/microtubule affinity-regulating kinase 2 |
chr20_-_1309809 | 0.49 |
ENST00000360779.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
chr6_-_117150198 | 0.48 |
ENST00000310357.3
ENST00000368549.3 ENST00000530250.1 |
GPRC6A
|
G protein-coupled receptor, family C, group 6, member A |
chr1_-_43855444 | 0.48 |
ENST00000372455.4
|
MED8
|
mediator complex subunit 8 |
chr6_-_88875654 | 0.48 |
ENST00000535130.1
|
CNR1
|
cannabinoid receptor 1 (brain) |
chr4_-_143227088 | 0.48 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr2_-_177502659 | 0.47 |
ENST00000295549.4
|
AC017048.3
|
long intergenic non-protein coding RNA 1116 |
chr2_-_175260368 | 0.47 |
ENST00000342016.3
ENST00000362053.5 |
CIR1
|
corepressor interacting with RBPJ, 1 |
chr12_+_50135351 | 0.47 |
ENST00000549445.1
ENST00000550951.1 ENST00000549385.1 ENST00000548713.1 ENST00000548201.1 |
TMBIM6
|
transmembrane BAX inhibitor motif containing 6 |
chr22_-_38902300 | 0.47 |
ENST00000403230.1
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17 |
chr11_-_72504637 | 0.47 |
ENST00000536377.1
ENST00000359373.5 |
STARD10
ARAP1
|
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr5_-_16742330 | 0.47 |
ENST00000505695.1
ENST00000427430.2 |
MYO10
|
myosin X |
chr17_+_65374075 | 0.47 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr8_+_128748308 | 0.46 |
ENST00000377970.2
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr1_-_152131703 | 0.46 |
ENST00000316073.3
|
RPTN
|
repetin |
chr4_+_86525299 | 0.46 |
ENST00000512201.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr11_+_71249071 | 0.45 |
ENST00000398534.3
|
KRTAP5-8
|
keratin associated protein 5-8 |
chr15_+_80733570 | 0.45 |
ENST00000533983.1
ENST00000527771.1 ENST00000525103.1 |
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr1_+_152956549 | 0.45 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr7_+_134464376 | 0.45 |
ENST00000454108.1
ENST00000361675.2 |
CALD1
|
caldesmon 1 |
chr6_+_12290586 | 0.45 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
chr18_+_60382672 | 0.45 |
ENST00000400316.4
ENST00000262719.5 |
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1 |
chr7_+_134551583 | 0.45 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.6 | 3.0 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.6 | 6.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 2.4 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 1.8 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.4 | 1.2 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.4 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 2.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 2.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 1.5 | GO:0010157 | response to chlorate(GO:0010157) |
0.4 | 1.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 1.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.0 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.3 | 0.6 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.3 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.9 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 0.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.3 | 1.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.3 | 4.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 1.4 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 2.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 1.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 0.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.6 | GO:1903314 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.2 | 0.6 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 2.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 3.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 2.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.6 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 1.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.2 | 1.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 1.3 | GO:0044256 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.2 | 1.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.1 | 0.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 2.0 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 3.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.5 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.8 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 0.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.1 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 3.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.3 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.1 | 0.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 1.0 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.2 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.3 | GO:0032489 | aminophospholipid transport(GO:0015917) regulation of Cdc42 protein signal transduction(GO:0032489) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0042668 | inhibition of neuroepithelial cell differentiation(GO:0002085) trochlear nerve development(GO:0021558) auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
0.1 | 1.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 2.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 3.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.2 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.1 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.4 | GO:0035864 | response to potassium ion(GO:0035864) |
0.1 | 0.4 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 2.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.1 | 0.7 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.3 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.3 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.4 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.4 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.2 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.1 | 0.4 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.6 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 1.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 3.4 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.4 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 1.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 1.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 1.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.5 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.0 | 1.6 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.0 | 1.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 2.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 1.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.8 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.3 | GO:0051964 | signal complex assembly(GO:0007172) netrin-activated signaling pathway(GO:0038007) negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 0.3 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.1 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.0 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.0 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.5 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.1 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
0.0 | 0.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 1.2 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 3.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 3.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 1.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.4 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 3.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 2.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 1.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 1.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 3.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 2.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 9.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 3.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 5.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) I band(GO:0031674) |
0.0 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 1.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 3.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.8 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 6.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 3.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 1.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.4 | 1.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 2.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 3.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.8 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 2.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 1.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 0.6 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.2 | 2.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.8 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 1.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.1 | 2.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 3.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.7 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 2.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 0.5 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.6 | GO:004320 |